The global Hematology Instruments and Reagents market estimated at US$7.63 billion in the year 2021 is now projected to grow at a CAGR of 8.86% and reach US$12.69 billion by 2027.
The research report provides a comprehensive review of market trends (Technology, Product and Application analysis), market growth drivers, PEST Analysis (Political, Economic, Social and Technological Analysis) Market growth inhibitors, and strategic industry activities and SWOT Analysis of key players in the market. The report provides market estimates and forecast for geographic markets such as the North America (United States, Canada, Mexico and Rest of North America), South America (Brazil, Argentina Chile Colombia Peru Venezuela Ecuador and Rest of South America), Europe (Germany, France, U.K., Russia, Italy, Spain, Sweden, Netherlands, Poland, Austria, Belgium, Finland, Norway, Switzerland, Denmark, Czech Republic, Portugal and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Philippines, Malaysia and Rest of Asia-Pacific), Middle East (Iran, Turkey, Kuwait, UAE, Israel, Oman, Bahrain, Saudi Arabia, Qatar, Egypt and Rest of Middle East) & Africa.
North American hematology instruments and reagents market is expected to grow significantly over the forecast period. This growth can be attributed to the robust presence of major players and increasing investment to develop novel and higher accurate result generating medical devices. U.S. contributed around 78% of the total North American hematology instruments and reagents market and is estimated to have a market value of US$2.26 billion in the year 2021. Among the other noteworthy geographic markets are Canada and Mexico, each forecast to grow at 5.49% and 4.20% respectively over the 2021-2027 period.
Asia Pacific hematology instruments and reagents market is anticipated to witness an upsurge owing to the governments of these regions imposing favorable regulations and compliances for the consumption of advanced medical instrumentations in countries including China, Japan and India. China is expected to dominate the Asia-Pacific market and reach a market size of US$2.81 billion by 2027.
Within Europe, France, Germany, and the U.K. are the key countries responsible for the significant growth of the regional market. Germany is expected to grow at a fastest CAGR of 6.93% over the forecast period.
Meanwhile, the Middle East & Africa is expected to show limited growth due to the strong presence of under-developed countries in Africa who are still struggling to meet technology standards. However, any growth that the region experiences is expected to come from developing Middle Eastern nations such as Qatar, U.A.E, and Oman due to a similar growth pattern as the Asia Pacific.
Key players profiled in the report include Abbott Diagnostics; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Drucker Diagnostics; Horiba Ltd.; Instrumentation Laboratory Inc.; Merck KGaA; Roche Diagnostics AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Siemens Healthineers; Sysmex America Inc.; Sysmex Corporation and Tcoag Ireland Ltd., among others.
Research Methodology
